Gå till Affärer
Hälsovård | Riskkapital

Avicenna Holdings Limited has been acquired by Juno Health

The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.

Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.

Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.

Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”

Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.

Prata med transaktionsteamet

Michael Jewell

Partner
London, Storbritannien
Oaklins Cavendish

Rebecca McCredie

Director
London, Storbritannien
Oaklins Cavendish

Relaterade affärer

Jeco Energies has sold a significant minority interest to NPM Capital
Riskkapital | Energi

Jeco Energies has sold a significant minority interest to NPM Capital

NPM Capital has acquired a significant minority interest in Jeco Energies. By teaming up with NPM Capital, Jeco Energies is ready for the next step in its remarkable growth trajectory and strengthening its position as the leading industrial energy solutions provider.

Lär dig mer
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Hälsovård

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Lär dig mer
Groupe JVS has completed an LBO with Capza and Bpifrance
Riskkapital | TMT

Groupe JVS has completed an LBO with Capza and Bpifrance

The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.

Lär dig mer